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The Sarah Cannon Blood Cancer Network (SCBCN) consists
of 6 programs in the US performing over 850 HSCTs annu-
ally. A goal was established to develop a single set of stan-
dard operating procedures (SOP) that would support
Network members. This standardization project was guided
by four principles: Quality, Efﬁciency, Democracy, and
Collaboration.
A BMT physician and Program Quality Manager were
established as co-chairs of the SOP Standardization Com-
mittee. Each BMT program identiﬁed work group repre-
sentatives from clinical, collection and processing. Processes
were established including identifying the SOP team leads
and development teams, collection of more than 300 SOPs
from each BMT program, drafting of standardized SOPs,
soliciting program input, dispute resolution, and approval.
The SOP Review Process was coordinated by a project
manager.
The SOP standardization process resulted in the creation of
approximately 70 Network SOPs. The project of SOP
standardization was started in October of 2011, and the
standardized SOPs were made available for local approval
and implementation in early 2013. Programs had the
freedom to customize the Network SOPs for program-
speciﬁc needs but were not to remove core content. SOP
maintenance including routine review is managed by a
continuing Network SOP committee with representation
from clinical, collection and processing laboratory staff in
each program. This committee meets monthly by confer-
ence call and reviews SOPs per an annual review calendar.
One SOP is selected each quarter and monitored for “drift”
from the Network template SOP. Five of the network
programs underwent FACT inspection and found the
network SOPs to be helpful in preparing for and passing
the inspection.
Network-wide development required resource and time
commitment from all programs. A common quality plan hel-
ped all institutions meet regulatory requirements and com-
mon outcome measures. Ongoing commitment and review of
the SOPs is required to prevent institutional drift and update
SOPs to meet any changes in regulatory requirements.529
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Austin, Texas is one of the fastest growing cities in the United
States. Cancer care in Austin is driven by strong community
physicians, dominated by Texas Oncology. In 2010, several
foundations studied cancer care in the Austin community
and found the largest service gap to be in Hematopoietic
Stem Cell Transplantation (HSCT). At the end of 2012, four
distinct entities, St. David’s South Austin Medical Center,
Texas Oncology, Texas Transplant Institute at Methodist
Hospital in San Antonio, and Sarah Cannon came together to
create an HSCT program in Austin. With each providing a
unique and needed component, the Austin program was
started in February 2014, completed their ﬁrst FACT inspec-
tion as a non-contiguous clinical program in conjunctionwith Texas Transplant Institute in July 2014, and is expected
to achieve full FACT accreditation by the Fall of 2014. The
collaboration between the four parties has led to faster-than-
expected program creation and ensured the quality, service,
and clinical excellence imperative in the treatment of HSCT
patients.
Eachmember of the collaboration team brought a needed set
of skills, knowledge, and effort that were essential in the
successful implementation. These included:
St. David’s South Austin Medical Center: The hospital, along
with its sponsor organizations, Hospital Corporation of
America (HCA) and the St. David’s Foundation, provided the
infrastructure needed, including the staff, equipment, sup-
plies and a new unit and clinic speciﬁcally designed for the
care of HSCT patients.
Texas Transplant Institute/Methodist Hospital: Texas Trans-
plant Institute, a well-established provider of HSCT services,
provided the clinical expertise through physician coverage,
guidance, nurse/technician education, and quality manage-
ment. Cell Therapy Processing services are provided by
Methodist Hospital.
Texas Oncology: The Austin-based community oncologists
established patient requirements, smoothed transitions, and
actively supported the program.
Sarah Cannon Blood Cancer Network: The SCBCN provided
standardized policies, procedures, and quality management
plans based on the best practices of the network facilities.
This collaborative organization composes a model of inte-
gration for new programs going forward. As more commu-
nities grow in their need for clinically-excellent stem cell
transplants close to home, this process provides a roadmap
for program creation in the future.
St. David’s South Austin Medical Center Adult Blood and
Marrow Transplant Program is a non-contiguous program
in partnership with Texas Transplant Institute of Meth-
odist Hospital that share a single medical director. Both
programs share common protocols, procedures, quality
management systems and staff training and compe-
tencies. Both programs participate regularly to review
clinical results: morbidity and mortality, quality
improvement and performance.530
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The National Marrow Donor Program (NMDP) works to
facilitate life-saving unrelated donor transplants for patients
with hematologic malignancies like leukemia, lymphoma
and sickle cell disease. The NMDP’s transplant center
network includes 143 centers across the country along with
donor centers, apheresis and collections centers as well as
cord blood banks. The NMDP surveyed its transplant center
network to better understand the scope of payer policy is-
sues transplant centers are facing. Fifty-six transplants
responded to the survey for a response rate of 39%. The
survey had four main focus areas: Medicare, Medicaid,
commercial payers and the Affordable Care Act (ACA). These
four areas have each been problematic for transplant cen-
ters for various reasons in the areas of reimbursement,
beneﬁt restrictions, covered disease indications and guide-
lines for transplantation and network inclusion. The survey
was conducted to formally assess the current standing and
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implementation of the ACA in early 2014. In terms of
Medicaid problems, the survey found that transplant cen-
ters have considerable issues with Medicaid reimbursement
rates (45%), prior authorization issues (46%), beneﬁt re-
strictions (38%) and coverage for speciﬁc clinical indications
(32%). Transplant centers issues with Medicare centered on
coverage for certain indications (71%) with some concern for
the current Medicare reimbursement rate (30%). Commer-
cial payers were rated by transplant centers to have minor
(32%) or some issues (43%) when it comes to the scope of
overall issues transplant centers face. Respondents gave
qualitative responses about how the ACA is impacting their
transplant center and patient populations. While a few re-
spondents provided positive anecdotes about expanded
patient access to care through the ACA, many respondents
discussed network inclusion issues, problems with home
health care, beneﬁt confusion and sincere concerns with
pharmaceutical beneﬁt restrictions. The survey results will
direct the efforts of the NMDP’s Payer Policy team and help
to inform the transplant community about common payer
challenges.531
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The establishment of a Quality Management System (QMS)
according to FACT e JACIE standards in a BMTcenter is a very
laborious project. Involvement of all personnel implicated in
collection, processing and clinical procedures is absolutely
necessary. Involvement includes strategic scheduling of QMS
development, writing of SOPs and documents, and imple-
mentation of the system. Deviations from the system as er-
rors, accidents and adverse reactions are very important to
be reported in a way to make corrections and improvement
in the system.
In our BMT center the duration of the task from the
beginning to the application for JACIE accreditation was four
years. A team of QM specialists was hired to work for the
common project. Doctors, nurses, technicians and the QM
specialists attended JACIE courses for center preparation.
Writing of SOPs and documents was shared between the
different departments. The QMS was implemented for the
ﬁrst time in June 2012. Audit of JACIE inspectors was per-
formed in March 2013 and the center was fully accredited in
October 2013.
During this task the personnel of the center acquired a lot
of experience regarding SOP management especially in the
ﬁeld of deviations from the system. Errors, accidents and
adverse reactions were completely reported and internal
audits were for this purpose. Following the incidences in
the three different phases: 1) organizing the QMS, 2)
implementation e JACIE inspection and 3) post-inspection
we realized that the number of deviations reported wascompletely different. There was an increase in the number
of deviations reported during the second phase starting at
the implementation and getting a peak during JACIE in-
spection. There was a 3fold increase compared to phase 1.
During the 3rdphase the number of deviations reported
has decrease and it is in a 2fold lower level compared to
the peak phase 2. Internal audits and inspections have
documented that this is due to corrections and improve-
ments of the system and the behavior of the personnel
and not due to relaxing which is an achievement for our
center.
In conclusion recording and dealing with adverse events as
well as reducing the actual number of deviations, as a result
of the better training and programming, could be a major
factor that improves the safety level.532
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Through the multi-year System Capacity Initiative and in
collaboration with hematopoietic cell transplant (HCT)
experts and key stakeholders, National Marrow Donor
Program/Be The Match evaluated the impact of work-
force and infrastructure challenges on the utilization of
HCT. A key ﬁnding from the needs assessments (Majhail et
al. BBMT, 2012; Denzen, et al. BBMT, 2013) was that the
effectiveness of recruitment and retention efforts is
limited by work-related distress (e.g., burnout, moral
distress, and compassion fatigue) across the HCT work-
force. Although a recent evaluation by Shanafelt et al. (JCO,
2014) identiﬁed a burnout rate of 44.7% in almost 3000
